# Roblox Corporation timeline entity: /record/roblox.md id: ent_roblox ## undated - undated | registrant_name | Roblox Corp | valid | [clm_0325D0C22AFD](/claim/clm_0325D0C22AFD.md) - undated | cik | 0001315098 | valid | [clm_06A6CE6892B0](/claim/clm_06A6CE6892B0.md) - undated | ticker | RBLX | valid | [clm_116149970F2D](/claim/clm_116149970F2D.md) - undated | listed_on | NYSE | valid | [clm_5F6AA5BEE0E3](/claim/clm_5F6AA5BEE0E3.md) - undated | state_of_incorporation | NV | valid | [clm_63BD13509BD9](/claim/clm_63BD13509BD9.md) - undated | fiscal_year_end | 12-31 | valid | [clm_7814579391C4](/claim/clm_7814579391C4.md) - undated | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_B1C4F8FE48E7](/claim/clm_B1C4F8FE48E7.md) - undated | owned_by | Altos Ventures | unverified | [clm_0E1961EE2A20](/claim/clm_0E1961EE2A20.md) - undated | legal_form | Delaware corporation | unverified | [clm_843A6A596936](/claim/clm_843A6A596936.md) - undated | produces | Roblox Studio | unverified | [clm_A48A8F01633D](/claim/clm_A48A8F01633D.md) - undated | country | United States | unverified | [clm_A954E6B4B2D6](/claim/clm_A954E6B4B2D6.md) - undated | website | https://corp.roblox.com/ | unverified | [clm_EFEC0ED51513](/claim/clm_EFEC0ED51513.md) ## 2019 - 2019-12-31 to 2020-12-31 | revenue | 508,393,000 United States dollar | superseded | [clm_115389C83C24](/claim/clm_115389C83C24.md) - 2019-12-31 to 2020-03-31 | cash_and_equivalents | 301,493,000 United States dollar | superseded | [clm_42936562A2C4](/claim/clm_42936562A2C4.md) - 2019-12-31 to 2020-12-31 | research_and_development | 107,095,000 United States dollar | superseded | [clm_88CB1657C66D](/claim/clm_88CB1657C66D.md) - 2019-12-31 to 2020-12-31 | operating_income | -76,440,000 United States dollar | superseded | [clm_DE9DB88A2A42](/claim/clm_DE9DB88A2A42.md) - 2019-12-31 to 2020-12-31 | net_income | -70,968,000 United States dollar | superseded | [clm_E9CFBE064938](/claim/clm_E9CFBE064938.md) ## 2020 - 2020-03-31 to 2020-06-30 | quarterly_research_and_development | 49,409,000 United States dollar | superseded | [clm_16ABA7E314F9](/claim/clm_16ABA7E314F9.md) - 2020-03-31 to 2020-06-30 | quarterly_net_income | -74,379,000 United States dollar | superseded | [clm_59D9FF938DD5](/claim/clm_59D9FF938DD5.md) - 2020-03-31 to 2020-06-30 | quarterly_operating_income | -72,966,000 United States dollar | superseded | [clm_AA9EC8350BD7](/claim/clm_AA9EC8350BD7.md) - 2020-03-31 to 2020-12-31 | cash_and_equivalents | 502,207,000 United States dollar | superseded | [clm_BD54A364AEA4](/claim/clm_BD54A364AEA4.md) - 2020-03-31 to 2020-06-30 | quarterly_revenue | 161,570,000 United States dollar | superseded | [clm_C5080B52906C](/claim/clm_C5080B52906C.md) - 2020-06-30 to 2020-09-30 | quarterly_revenue | 200,392,000 United States dollar | superseded | [clm_44BCA0544539](/claim/clm_44BCA0544539.md) - 2020-06-30 to 2020-09-30 | quarterly_operating_income | -73,046,000 United States dollar | superseded | [clm_691DC5EDE397](/claim/clm_691DC5EDE397.md) - 2020-06-30 to 2020-09-30 | quarterly_research_and_development | 40,249,000 United States dollar | superseded | [clm_7EF500FB69F0](/claim/clm_7EF500FB69F0.md) - 2020-06-30 to 2020-09-30 | quarterly_net_income | -71,521,000 United States dollar | superseded | [clm_D597DC5503C8](/claim/clm_D597DC5503C8.md) - 2020-09-30 to 2021-03-31 | quarterly_operating_income | -51,518,000 United States dollar | superseded | [clm_94434F4ACABB](/claim/clm_94434F4ACABB.md) - 2020-09-30 to 2021-03-31 | quarterly_research_and_development | 51,708,000 United States dollar | superseded | [clm_9EEEBFA026D5](/claim/clm_9EEEBFA026D5.md) - 2020-09-30 to 2021-03-31 | quarterly_net_income | -48,613,000 United States dollar | superseded | [clm_D9DF7866E5CD](/claim/clm_D9DF7866E5CD.md) - 2020-09-30 to 2021-03-31 | quarterly_revenue | 251,914,000 United States dollar | superseded | [clm_FCAD0ADF0D81](/claim/clm_FCAD0ADF0D81.md) - 2020-12-31 to 2021-12-31 | net_income | -253,254,000 United States dollar | superseded | [clm_3FA9EE92867A](/claim/clm_3FA9EE92867A.md) - 2020-12-31 to 2021-03-31 | cash_and_equivalents | 893,943,000 United States dollar | superseded | [clm_40D032F56C1B](/claim/clm_40D032F56C1B.md) - 2020-12-31 to 2021-03-31 | total_assets | 1,847,800,000 United States dollar | superseded | [clm_4FFC9A3E1202](/claim/clm_4FFC9A3E1202.md) - 2020-12-31 to 2021-03-31 | total_equity | -252,388,000 United States dollar | superseded | [clm_64D6F824638C](/claim/clm_64D6F824638C.md) - 2020-12-31 to 2021-12-31 | revenue | 923,885,000 United States dollar | superseded | [clm_804770EDBAC8](/claim/clm_804770EDBAC8.md) - 2020-12-31 to 2021-12-31 | operating_income | -266,137,000 United States dollar | superseded | [clm_EEB3741C0CAF](/claim/clm_EEB3741C0CAF.md) - 2020-12-31 to 2021-12-31 | research_and_development | 201,433,000 United States dollar | superseded | [clm_F33675CCFF59](/claim/clm_F33675CCFF59.md) ## 2021 - 2021-03-31 to 2021-06-30 | total_equity | 573,473,000 United States dollar | superseded | [clm_1C1DEE84BA5B](/claim/clm_1C1DEE84BA5B.md) - 2021-03-31 to 2021-06-30 | cash_and_equivalents | 1,600,530,000 United States dollar | superseded | [clm_244C63D6E91D](/claim/clm_244C63D6E91D.md) - 2021-03-31 to 2021-06-30 | quarterly_operating_income | -135,056,000 United States dollar | superseded | [clm_4679206B8E2C](/claim/clm_4679206B8E2C.md) - 2021-03-31 to 2021-06-30 | total_assets | 2,816,079,000 United States dollar | superseded | [clm_4D099846D2C9](/claim/clm_4D099846D2C9.md) - 2021-03-31 to 2021-06-30 | quarterly_net_income | -134,217,000 United States dollar | superseded | [clm_766EE1680FB2](/claim/clm_766EE1680FB2.md) - 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 96,644,000 United States dollar | superseded | [clm_8AA59D23DE05](/claim/clm_8AA59D23DE05.md) - 2021-03-31 to 2021-06-30 | quarterly_revenue | 386,976,000 United States dollar | superseded | [clm_D2F4C3F22039](/claim/clm_D2F4C3F22039.md) - 2021-06-30 to 2021-09-30 | quarterly_operating_income | -142,946,000 United States dollar | superseded | [clm_2CD5367903CD](/claim/clm_2CD5367903CD.md) - 2021-06-30 to 2021-09-30 | quarterly_net_income | -140,134,000 United States dollar | superseded | [clm_4CF70733AC89](/claim/clm_4CF70733AC89.md) - 2021-06-30 to 2021-09-30 | quarterly_revenue | 454,100,000 United States dollar | superseded | [clm_72DA911708FC](/claim/clm_72DA911708FC.md) - 2021-06-30 to 2021-09-30 | total_assets | 3,073,791,000 United States dollar | superseded | [clm_8C8044026D66](/claim/clm_8C8044026D66.md) - 2021-06-30 to 2021-09-30 | cash_and_equivalents | 1,780,262,000 United States dollar | superseded | [clm_D494B0FB0736](/claim/clm_D494B0FB0736.md) - 2021-06-30 to 2021-09-30 | total_equity | 526,690,000 United States dollar | superseded | [clm_E8FC34B7BB17](/claim/clm_E8FC34B7BB17.md) - 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 124,748,000 United States dollar | superseded | [clm_EA7AD376E6F4](/claim/clm_EA7AD376E6F4.md) - 2021-09-30 to 2022-03-31 | quarterly_research_and_development | 138,245,000 United States dollar | superseded | [clm_055E3C89F262](/claim/clm_055E3C89F262.md) - 2021-09-30 to 2022-03-31 | quarterly_operating_income | -77,446,000 United States dollar | superseded | [clm_39241943B614](/claim/clm_39241943B614.md) - 2021-09-30 to 2021-12-31 | total_equity | 593,717,000 United States dollar | superseded | [clm_3980BA94F555](/claim/clm_3980BA94F555.md) - 2021-09-30 to 2022-03-31 | quarterly_net_income | -74,002,000 United States dollar | superseded | [clm_7488A604B883](/claim/clm_7488A604B883.md) - 2021-09-30 to 2021-12-31 | cash_and_equivalents | 1,925,559,000 United States dollar | superseded | [clm_77AD77E5B5A1](/claim/clm_77AD77E5B5A1.md) - 2021-09-30 to 2021-12-31 | total_assets | 3,272,280,000 United States dollar | superseded | [clm_D3AC363B3113](/claim/clm_D3AC363B3113.md) - 2021-09-30 to 2022-03-31 | quarterly_revenue | 509,336,000 United States dollar | superseded | [clm_DCC8D25B6008](/claim/clm_DCC8D25B6008.md) - 2021-12-31 to 2022-12-31 | net_income | -491,651,000 United States dollar | superseded | [clm_1A0648C00482](/claim/clm_1A0648C00482.md) - 2021-12-31 to 2022-03-31 | total_assets | 4,560,596,000 United States dollar | superseded | [clm_38DEC440A555](/claim/clm_38DEC440A555.md) - 2021-12-31 to 2022-12-31 | research_and_development | 533,207,000 United States dollar | superseded | [clm_68B91B690231](/claim/clm_68B91B690231.md) - 2021-12-31 to 2022-12-31 | operating_income | -495,098,000 United States dollar | superseded | [clm_7403A65E7F87](/claim/clm_7403A65E7F87.md) - 2021-12-31 to 2022-03-31 | total_equity | 584,817,000 United States dollar | superseded | [clm_BAEA0A0175EE](/claim/clm_BAEA0A0175EE.md) - 2021-12-31 to 2022-03-31 | cash_and_equivalents | 3,004,300,000 United States dollar | superseded | [clm_BBD72E15FEA7](/claim/clm_BBD72E15FEA7.md) - 2021-12-31 to 2022-12-31 | revenue | 1,919,181,000 United States dollar | superseded | [clm_EC474B42B52D](/claim/clm_EC474B42B52D.md) ## 2022 - 2022-03-31 to 2022-06-30 | quarterly_revenue | 537,134,000 United States dollar | superseded | [clm_05142D04C698](/claim/clm_05142D04C698.md) - 2022-03-31 to 2022-06-30 | total_equity | 561,087,000 United States dollar | superseded | [clm_5AA6156FEF16](/claim/clm_5AA6156FEF16.md) - 2022-03-31 to 2022-06-30 | total_assets | 4,715,831,000 United States dollar | superseded | [clm_7EF9437C16BF](/claim/clm_7EF9437C16BF.md) - 2022-03-31 to 2022-06-30 | quarterly_research_and_development | 177,762,000 United States dollar | superseded | [clm_85A4728A5824](/claim/clm_85A4728A5824.md) - 2022-03-31 to 2022-06-30 | quarterly_operating_income | -151,611,000 United States dollar | superseded | [clm_867A334A295B](/claim/clm_867A334A295B.md) - 2022-03-31 to 2022-06-30 | cash_and_equivalents | 3,132,964,000 United States dollar | superseded | [clm_94B6A21E6426](/claim/clm_94B6A21E6426.md) - 2022-03-31 to 2022-06-30 | quarterly_net_income | -160,202,000 United States dollar | superseded | [clm_F0FB75F20912](/claim/clm_F0FB75F20912.md) - 2022-06-30 to 2022-09-30 | total_equity | 547,088,000 United States dollar | superseded | [clm_0F2FBA098A9C](/claim/clm_0F2FBA098A9C.md) - 2022-06-30 to 2022-09-30 | quarterly_research_and_development | 211,757,000 United States dollar | superseded | [clm_36AEB4009FDA](/claim/clm_36AEB4009FDA.md) - 2022-06-30 to 2022-09-30 | quarterly_net_income | -176,440,000 United States dollar | superseded | [clm_61E3E4451377](/claim/clm_61E3E4451377.md) - 2022-06-30 to 2022-09-30 | total_assets | 4,919,420,000 United States dollar | superseded | [clm_9E099023B75D](/claim/clm_9E099023B75D.md) - 2022-06-30 to 2022-09-30 | cash_and_equivalents | 3,075,475,000 United States dollar | superseded | [clm_DC743283D7CF](/claim/clm_DC743283D7CF.md) - 2022-06-30 to 2022-09-30 | quarterly_revenue | 591,207,000 United States dollar | superseded | [clm_E0D8953656A0](/claim/clm_E0D8953656A0.md) - 2022-06-30 to 2022-09-30 | quarterly_operating_income | -170,267,000 United States dollar | superseded | [clm_F1015D9EFC44](/claim/clm_F1015D9EFC44.md) - 2022-09-30 to 2022-12-31 | total_assets | 5,038,324,000 United States dollar | superseded | [clm_292B3B42573E](/claim/clm_292B3B42573E.md) - 2022-09-30 to 2022-12-31 | cash_and_equivalents | 3,021,507,000 United States dollar | superseded | [clm_84415F033B90](/claim/clm_84415F033B90.md) - 2022-09-30 to 2023-03-31 | quarterly_operating_income | -300,007,000 United States dollar | superseded | [clm_879624EEFE78](/claim/clm_879624EEFE78.md) - 2022-09-30 to 2023-03-31 | quarterly_net_income | -297,798,000 United States dollar | superseded | [clm_8E21DC76CC39](/claim/clm_8E21DC76CC39.md) - 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 235,551,000 United States dollar | superseded | [clm_C1EE6FFD6D84](/claim/clm_C1EE6FFD6D84.md) - 2022-09-30 to 2023-03-31 | quarterly_revenue | 517,707,000 United States dollar | superseded | [clm_C4FB015888A2](/claim/clm_C4FB015888A2.md) - 2022-09-30 to 2022-12-31 | total_equity | 423,717,000 United States dollar | superseded | [clm_E4E0E2B42390](/claim/clm_E4E0E2B42390.md) - 2022-12-31 to 2023-03-31 | total_assets | 5,375,487,000 United States dollar | superseded | [clm_1883D2DA19CA](/claim/clm_1883D2DA19CA.md) - 2022-12-31 to 2023-12-31 | revenue | 2,225,052,000 United States dollar | superseded | [clm_39201CFB1A24](/claim/clm_39201CFB1A24.md) - 2022-12-31 to 2023-12-31 | research_and_development | 873,477,000 United States dollar | superseded | [clm_4231D3AED84C](/claim/clm_4231D3AED84C.md) - 2022-12-31 to 2023-03-31 | total_equity | 306,026,000 United States dollar | superseded | [clm_48C32398662A](/claim/clm_48C32398662A.md) - 2022-12-31 to 2023-12-31 | net_income | -924,366,000 United States dollar | superseded | [clm_A8F63D9303E8](/claim/clm_A8F63D9303E8.md) - 2022-12-31 to 2023-03-31 | cash_and_equivalents | 2,977,474,000 United States dollar | superseded | [clm_CFE35AFED70A](/claim/clm_CFE35AFED70A.md) - 2022-12-31 to 2023-12-31 | operating_income | -923,784,000 United States dollar | superseded | [clm_EB994B36F6B5](/claim/clm_EB994B36F6B5.md) ## 2023 - 2023-03-31 to 2023-06-30 | quarterly_operating_income | -289,847,000 United States dollar | superseded | [clm_267D5C8E54FD](/claim/clm_267D5C8E54FD.md) - 2023-03-31 to 2023-06-30 | cash_and_equivalents | 828,129,000 United States dollar | superseded | [clm_41F4776F966E](/claim/clm_41F4776F966E.md) - 2023-03-31 to 2023-06-30 | quarterly_revenue | 655,344,000 United States dollar | superseded | [clm_5F4D280AACBF](/claim/clm_5F4D280AACBF.md) - 2023-03-31 to 2023-06-30 | total_equity | 247,842,000 United States dollar | superseded | [clm_7558AA772FB4](/claim/clm_7558AA772FB4.md) - 2023-03-31 to 2023-06-30 | total_assets | 5,471,460,000 United States dollar | superseded | [clm_A1FC748735C1](/claim/clm_A1FC748735C1.md) - 2023-03-31 to 2023-06-30 | quarterly_net_income | -268,313,000 United States dollar | superseded | [clm_A3CEF32CB734](/claim/clm_A3CEF32CB734.md) - 2023-03-31 to 2023-06-30 | quarterly_research_and_development | 275,537,000 United States dollar | superseded | [clm_EBB52533E283](/claim/clm_EBB52533E283.md) - 2023-06-30 to 2023-09-30 | quarterly_operating_income | -313,989,000 United States dollar | superseded | [clm_34547F93115D](/claim/clm_34547F93115D.md) - 2023-06-30 to 2023-09-30 | quarterly_revenue | 680,766,000 United States dollar | superseded | [clm_53755B15C809](/claim/clm_53755B15C809.md) - 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 315,319,000 United States dollar | superseded | [clm_785D47A8A189](/claim/clm_785D47A8A189.md) - 2023-06-30 to 2023-09-30 | total_assets | 5,599,277,000 United States dollar | superseded | [clm_83C7FB3371A8](/claim/clm_83C7FB3371A8.md) - 2023-06-30 to 2023-09-30 | cash_and_equivalents | 520,264,000 United States dollar | superseded | [clm_BB667A198AB6](/claim/clm_BB667A198AB6.md) - 2023-06-30 to 2023-09-30 | total_equity | 168,497,000 United States dollar | superseded | [clm_C76DD9BA7576](/claim/clm_C76DD9BA7576.md) - 2023-06-30 to 2023-09-30 | quarterly_net_income | -282,777,000 United States dollar | superseded | [clm_F133FEFC6553](/claim/clm_F133FEFC6553.md) - 2023-09-13 | board_member | Jason Kilar | valid | [clm_B5321AAA0737](/claim/clm_B5321AAA0737.md) - 2023-09-30 to 2024-03-31 | quarterly_revenue | 713,225,000 United States dollar | superseded | [clm_1B9A12062B26](/claim/clm_1B9A12062B26.md) - 2023-09-30 to 2023-12-31 | cash_and_equivalents | 580,049,000 United States dollar | superseded | [clm_44649EF38D33](/claim/clm_44649EF38D33.md) - 2023-09-30 to 2024-03-31 | quarterly_net_income | -277,158,000 United States dollar | superseded | [clm_5F86C11E2961](/claim/clm_5F86C11E2961.md) - 2023-09-30 to 2023-12-31 | total_assets | 5,754,130,000 United States dollar | superseded | [clm_79FC8062BFE5](/claim/clm_79FC8062BFE5.md) - 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 321,613,000 United States dollar | superseded | [clm_875E9C905FAB](/claim/clm_875E9C905FAB.md) - 2023-09-30 to 2023-12-31 | total_equity | 125,786,000 United States dollar | superseded | [clm_C19213C6397A](/claim/clm_C19213C6397A.md) - 2023-09-30 to 2024-03-31 | quarterly_operating_income | -300,038,000 United States dollar | superseded | [clm_CCD60E65CA50](/claim/clm_CCD60E65CA50.md) - 2023-12-31 to 2024-12-31 | net_income | -1,151,946,000 United States dollar | superseded | [clm_0410F5AED439](/claim/clm_0410F5AED439.md) - 2023-12-31 to 2024-12-31 | operating_income | -1,259,067,000 United States dollar | superseded | [clm_5B68661DCCCE](/claim/clm_5B68661DCCCE.md) - 2023-12-31 to 2024-03-31 | total_assets | 6,168,078,000 United States dollar | superseded | [clm_621412B664E9](/claim/clm_621412B664E9.md) - 2023-12-31 to 2024-03-31 | total_equity | 76,290,000 United States dollar | superseded | [clm_6E440EA30754](/claim/clm_6E440EA30754.md) - 2023-12-31 to 2024-03-31 | cash_and_equivalents | 678,466,000 United States dollar | superseded | [clm_7B187A123042](/claim/clm_7B187A123042.md) - 2023-12-31 to 2024-12-31 | revenue | 2,799,274,000 United States dollar | superseded | [clm_C53871F6B97C](/claim/clm_C53871F6B97C.md) - 2023-12-31 to 2024-12-31 | research_and_development | 1,253,598,000 United States dollar | superseded | [clm_EB1B036990D8](/claim/clm_EB1B036990D8.md) ## 2024 - 2024-03-31 to 2024-06-30 | quarterly_revenue | 801,300,000 United States dollar | superseded | [clm_131FABA3DCD6](/claim/clm_131FABA3DCD6.md) - 2024-03-31 to 2024-06-30 | total_assets | 6,314,671,000 United States dollar | superseded | [clm_55760BF6DC7B](/claim/clm_55760BF6DC7B.md) - 2024-03-31 to 2024-06-30 | quarterly_operating_income | -302,328,000 United States dollar | superseded | [clm_75C0044BBCE8](/claim/clm_75C0044BBCE8.md) - 2024-03-31 to 2024-06-30 | cash_and_equivalents | 866,414,000 United States dollar | superseded | [clm_84D4FC64E59D](/claim/clm_84D4FC64E59D.md) - 2024-03-31 to 2024-06-30 | total_equity | 71,601,000 United States dollar | superseded | [clm_9397C63BCA4D](/claim/clm_9397C63BCA4D.md) - 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 362,065,000 United States dollar | superseded | [clm_CC3FE18CFEFB](/claim/clm_CC3FE18CFEFB.md) - 2024-03-31 to 2024-06-30 | quarterly_net_income | -270,604,000 United States dollar | superseded | [clm_F28D047BCA91](/claim/clm_F28D047BCA91.md) - 2024-06-30 to 2024-09-30 | cash_and_equivalents | 966,406,000 United States dollar | superseded | [clm_2F896976319D](/claim/clm_2F896976319D.md) - 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 361,684,000 United States dollar | superseded | [clm_43C67BBDCA3E](/claim/clm_43C67BBDCA3E.md) - 2024-06-30 to 2024-09-30 | quarterly_revenue | 893,543,000 United States dollar | superseded | [clm_45095A43809D](/claim/clm_45095A43809D.md) - 2024-06-30 to 2024-09-30 | total_equity | 121,506,000 United States dollar | superseded | [clm_625BC53F49FD](/claim/clm_625BC53F49FD.md) - 2024-06-30 to 2024-09-30 | quarterly_operating_income | -237,949,000 United States dollar | superseded | [clm_B6FFD8295BDB](/claim/clm_B6FFD8295BDB.md) - 2024-06-30 to 2024-09-30 | quarterly_net_income | -205,883,000 United States dollar | superseded | [clm_DB77BD5ABB7F](/claim/clm_DB77BD5ABB7F.md) - 2024-06-30 to 2024-09-30 | total_assets | 6,470,516,000 United States dollar | superseded | [clm_F753EC58B116](/claim/clm_F753EC58B116.md) - 2024-09-30 to 2025-03-31 | quarterly_net_income | -239,324,000 United States dollar | superseded | [clm_148D3F4A76A1](/claim/clm_148D3F4A76A1.md) - 2024-09-30 to 2024-12-31 | cash_and_equivalents | 602,631,000 United States dollar | superseded | [clm_55E105CE288D](/claim/clm_55E105CE288D.md) - 2024-09-30 to 2025-03-31 | quarterly_operating_income | -278,928,000 United States dollar | superseded | [clm_BEEFF5897295](/claim/clm_BEEFF5897295.md) - 2024-09-30 to 2025-03-31 | quarterly_revenue | 918,953,000 United States dollar | superseded | [clm_C6054D06657B](/claim/clm_C6054D06657B.md) - 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 365,424,000 United States dollar | superseded | [clm_C81CFD2C536F](/claim/clm_C81CFD2C536F.md) - 2024-09-30 to 2024-12-31 | total_assets | 6,687,962,000 United States dollar | superseded | [clm_DAB0321672FE](/claim/clm_DAB0321672FE.md) - 2024-09-30 to 2024-12-31 | total_equity | 189,905,000 United States dollar | superseded | [clm_EF9E9CE2CD4E](/claim/clm_EF9E9CE2CD4E.md) - 2024-12-31 to 2025-12-31 | net_income | -935,384,000 United States dollar | superseded | [clm_13B685050E1B](/claim/clm_13B685050E1B.md) - 2024-12-31 to 2025-03-31 | total_equity | 221,446,000 United States dollar | superseded | [clm_27571584DC29](/claim/clm_27571584DC29.md) - 2024-12-31 to 2025-12-31 | operating_income | -1,063,317,000 United States dollar | superseded | [clm_65377FBB9CEF](/claim/clm_65377FBB9CEF.md) - 2024-12-31 to 2025-12-31 | revenue | 3,601,979,000 United States dollar | superseded | [clm_B4F2937158C4](/claim/clm_B4F2937158C4.md) - 2024-12-31 to 2025-12-31 | research_and_development | 1,444,207,000 United States dollar | superseded | [clm_D1244AAC52E8](/claim/clm_D1244AAC52E8.md) - 2024-12-31 to 2025-03-31 | total_assets | 7,175,003,000 United States dollar | superseded | [clm_D7B909840BA5](/claim/clm_D7B909840BA5.md) - 2024-12-31 to 2025-03-31 | cash_and_equivalents | 711,683,000 United States dollar | superseded | [clm_DF35B6CA0BF0](/claim/clm_DF35B6CA0BF0.md) ## 2025 - 2025-02-28 | owned_by | David Baszucki | unverified | [clm_52CA57D82B7A](/claim/clm_52CA57D82B7A.md) - 2025-03-31 to 2025-06-30 | total_assets | 7,452,249,000 United States dollar | superseded | [clm_03C53060720D](/claim/clm_03C53060720D.md) - 2025-03-31 to 2025-06-30 | total_equity | 310,687,000 United States dollar | superseded | [clm_52F91E39228F](/claim/clm_52F91E39228F.md) - 2025-03-31 to 2025-06-30 | quarterly_revenue | 1,035,207,000 United States dollar | superseded | [clm_8C7D6D2BE9A1](/claim/clm_8C7D6D2BE9A1.md) - 2025-03-31 to 2025-06-30 | quarterly_operating_income | -254,709,000 United States dollar | superseded | [clm_D0399B33883F](/claim/clm_D0399B33883F.md) - 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 374,600,000 United States dollar | superseded | [clm_D1AF7A49D316](/claim/clm_D1AF7A49D316.md) - 2025-03-31 to 2025-06-30 | cash_and_equivalents | 1,158,680,000 United States dollar | superseded | [clm_E5C0BEC1922E](/claim/clm_E5C0BEC1922E.md) - 2025-03-31 to 2025-06-30 | quarterly_net_income | -215,056,000 United States dollar | superseded | [clm_F02FB4B7855C](/claim/clm_F02FB4B7855C.md) - 2025-05-01 to 2026-10-28 | market_cap | 46,799,000,000 United States dollar | superseded | [clm_2AFF7CBA3585](/claim/clm_2AFF7CBA3585.md) - 2025-06-30 to 2025-09-30 | quarterly_revenue | 1,080,677,000 United States dollar | superseded | [clm_00AB591C0448](/claim/clm_00AB591C0448.md) - 2025-06-30 to 2025-09-30 | quarterly_operating_income | -322,460,000 United States dollar | superseded | [clm_09FA6244D4B5](/claim/clm_09FA6244D4B5.md) - 2025-06-30 | cfo | Naveen Chopra | valid | [clm_45018C4C9768](/claim/clm_45018C4C9768.md) - 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 384,996,000 United States dollar | superseded | [clm_87B42B86B67B](/claim/clm_87B42B86B67B.md) - 2025-06-30 to 2025-09-30 | cash_and_equivalents | 994,570,000 United States dollar | superseded | [clm_9CDCCFFBC62F](/claim/clm_9CDCCFFBC62F.md) - 2025-06-30 to 2025-09-30 | total_assets | 7,845,571,000 United States dollar | superseded | [clm_AAFD17D43A86](/claim/clm_AAFD17D43A86.md) - 2025-06-30 to 2025-09-30 | quarterly_net_income | -278,375,000 United States dollar | superseded | [clm_C0444CF6C994](/claim/clm_C0444CF6C994.md) - 2025-06-30 to 2025-09-30 | total_equity | 353,221,000 United States dollar | superseded | [clm_CE47C9C51D12](/claim/clm_CE47C9C51D12.md) - 2025-09-30 to 2026-03-31 | quarterly_revenue | 1,359,646,000 United States dollar | superseded | [clm_2E9E3CCF7DAA](/claim/clm_2E9E3CCF7DAA.md) - 2025-09-30 to 2025-12-31 | cash_and_equivalents | 1,016,825,000 United States dollar | superseded | [clm_47B42AE29104](/claim/clm_47B42AE29104.md) - 2025-09-30 to 2025-12-31 | total_equity | 407,569,000 United States dollar | superseded | [clm_53B6B784DD59](/claim/clm_53B6B784DD59.md) - 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 398,306,000 United States dollar | superseded | [clm_84A7AB939D6E](/claim/clm_84A7AB939D6E.md) - 2025-09-30 to 2026-03-31 | quarterly_net_income | -255,626,000 United States dollar | superseded | [clm_A6C171A1B223](/claim/clm_A6C171A1B223.md) - 2025-09-30 to 2025-12-31 | total_assets | 8,590,809,000 United States dollar | superseded | [clm_B6F31DB5499D](/claim/clm_B6F31DB5499D.md) - 2025-09-30 to 2026-03-31 | quarterly_operating_income | -296,535,000 United States dollar | superseded | [clm_C5F23B5E4E4B](/claim/clm_C5F23B5E4E4B.md) - 2025-12-31 | net_income | -1,065,057,000 United States dollar | valid | [clm_57E0DF901B56](/claim/clm_57E0DF901B56.md) - 2025-12-31 | operating_income | -1,232,342,000 United States dollar | valid | [clm_7503CCC091DA](/claim/clm_7503CCC091DA.md) - 2025-12-31 to 2026-03-31 | total_assets | 9,557,118,000 United States dollar | superseded | [clm_7B1B7FA4A92A](/claim/clm_7B1B7FA4A92A.md) - 2025-12-31 to 2026-03-31 | total_equity | 394,484,000 United States dollar | superseded | [clm_96F55297F53A](/claim/clm_96F55297F53A.md) - 2025-12-31 to 2026-03-31 | cash_and_equivalents | 1,205,319,000 United States dollar | superseded | [clm_A0F5D8B0E408](/claim/clm_A0F5D8B0E408.md) - 2025-12-31 | revenue | 4,890,551,000 United States dollar | valid | [clm_BE0C02A13066](/claim/clm_BE0C02A13066.md) - 2025-12-31 | research_and_development | 1,567,747,000 United States dollar | valid | [clm_BF79A2B3520C](/claim/clm_BF79A2B3520C.md) ## 2026 - 2026-03-19 | board_member | Dennis Durkin | valid | [clm_2143CCCDE4D0](/claim/clm_2143CCCDE4D0.md) - 2026-03-31 to 2026-06-30 | quarterly_revenue | 1,442,000,000 United States dollar | superseded | [clm_243FA65F73C7](/claim/clm_243FA65F73C7.md) - 2026-03-31 to 2026-06-30 | cash_and_equivalents | 1,188,000,000 United States dollar | superseded | [clm_497753BE4F50](/claim/clm_497753BE4F50.md) - 2026-03-31 to 2026-06-30 | quarterly_operating_income | -294,000,000 United States dollar | superseded | [clm_9259BB4C4FC4](/claim/clm_9259BB4C4FC4.md) - 2026-03-31 to 2026-06-30 | quarterly_net_income | -246,000,000 United States dollar | superseded | [clm_C3270E358843](/claim/clm_C3270E358843.md) - 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 422,000,000 United States dollar | superseded | [clm_E1F3392EB411](/claim/clm_E1F3392EB411.md) - 2026-03-31 to 2026-06-30 | total_assets | 9,827,000,000 United States dollar | superseded | [clm_ED115CC2A438](/claim/clm_ED115CC2A438.md) - 2026-03-31 to 2026-06-30 | total_equity | 432,000,000 United States dollar | superseded | [clm_EE9CC4C53D08](/claim/clm_EE9CC4C53D08.md) - 2026-06-30 | quarterly_revenue | 1,469,000,000 United States dollar | valid | [clm_130487ED29E5](/claim/clm_130487ED29E5.md) - 2026-06-30 | quarterly_research_and_development | 420,000,000 United States dollar | valid | [clm_2A57F4AA7201](/claim/clm_2A57F4AA7201.md) - 2026-06-30 | cash_and_equivalents | 991,000,000 United States dollar | valid | [clm_397647948E78](/claim/clm_397647948E78.md) - 2026-06-30 | total_assets | 9,745,000,000 United States dollar | valid | [clm_6EDB5727BE54](/claim/clm_6EDB5727BE54.md) - 2026-06-30 | quarterly_net_income | -183,000,000 United States dollar | valid | [clm_AF36C998654E](/claim/clm_AF36C998654E.md) - 2026-06-30 | total_equity | 152,000,000 United States dollar | valid | [clm_E6F434EEA933](/claim/clm_E6F434EEA933.md) - 2026-06-30 | quarterly_operating_income | -229,000,000 United States dollar | valid | [clm_F2AB0CF4384F](/claim/clm_F2AB0CF4384F.md) - 2026-10-28 | market_cap | 38,910,000,000 United States dollar | unverified | [clm_A921D546E9C7](/claim/clm_A921D546E9C7.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.